Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV
収録刊行物
-
- Gastroenterology
-
Gastroenterology 143 (6), 1576-1585.e4, 2012-12
Elsevier BV